跳至主要内容
临床试验/IRCT20201006048950N3
IRCT20201006048950N3尚未招募2 期

The effect of alpha-blocker drugs on reducing the irritating symptoms caused by ureteral stent placement in patients undergoing surgery

Arak University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 81 years(—)
性别
All

入选标准

  • lack of Underlying disease, especially nephrogenic cardiovascular problems, allergies, other urological diseases, urinary retention, diabetes, malignancy in the urinary tract, chronic pelvic pain syndrome, lower urinary tract symptoms
  • No drug addiction
  • Age less than 81 years
  • Informed consent
  • One-sided G stent placement

排除标准

  • 未提供

研究者

相似试验